223 related articles for article (PubMed ID: 35853202)
41. Reduction of TMAO level enhances the stability of carotid atherosclerotic plaque through promoting macrophage M2 polarization and efferocytosis.
Shi W; Huang Y; Yang Z; Zhu L; Yu B
Biosci Rep; 2021 May; 41(6):. PubMed ID: 33969376
[TBL] [Abstract][Full Text] [Related]
42. Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets.
De Meyer GRY; Zurek M; Puylaert P; Martinet W
Nat Rev Cardiol; 2024 May; 21(5):312-325. PubMed ID: 38163815
[TBL] [Abstract][Full Text] [Related]
43. Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis.
Ngai D; Sukka SR; Tabas I
Front Immunol; 2024; 15():1403150. PubMed ID: 38873597
[TBL] [Abstract][Full Text] [Related]
44. Macrophage efferocytosis in health and disease.
Razi S; Yaghmoorian Khojini J; Kargarijam F; Panahi S; Tahershamsi Z; Tajbakhsh A; Gheibihayat SM
Cell Biochem Funct; 2023 Mar; 41(2):152-165. PubMed ID: 36794573
[TBL] [Abstract][Full Text] [Related]
45. Ca
Tajbakhsh A; Kovanen PT; Rezaee M; Banach M; Sahebkar A
J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31766552
[TBL] [Abstract][Full Text] [Related]
46. Regulation of efferocytosis by caspase-dependent apoptotic cell death in atherosclerosis.
Tajbakhsh A; Kovanen PT; Rezaee M; Banach M; Moallem SA; Sahebkar A
Int J Biochem Cell Biol; 2020 Mar; 120():105684. PubMed ID: 31911118
[TBL] [Abstract][Full Text] [Related]
47. Protective Functions of Liver X Receptor α in Established Vulnerable Plaques: Involvement of Regulating Endoplasmic Reticulum-Mediated Macrophage Apoptosis and Efferocytosis.
Che X; Xiao Q; Song W; Zhang H; Sun B; Geng N; Tao Z; Shao Q; Pu J
J Am Heart Assoc; 2021 May; 10(10):e018455. PubMed ID: 33969692
[TBL] [Abstract][Full Text] [Related]
48. The walking dead: macrophage inflammation and death in atherosclerosis.
Kavurma MM; Rayner KJ; Karunakaran D
Curr Opin Lipidol; 2017 Apr; 28(2):91-98. PubMed ID: 28134664
[TBL] [Abstract][Full Text] [Related]
49. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.
Kojima Y; Downing K; Kundu R; Miller C; Dewey F; Lancero H; Raaz U; Perisic L; Hedin U; Schadt E; Maegdefessel L; Quertermous T; Leeper NJ
J Clin Invest; 2014 Mar; 124(3):1083-97. PubMed ID: 24531546
[TBL] [Abstract][Full Text] [Related]
50. STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis.
Gong M; Zhuo X; Ma A
Med Sci Monit Basic Res; 2017 Jun; 23():240-249. PubMed ID: 28615615
[TBL] [Abstract][Full Text] [Related]
51. NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice.
Grootaert MOJ; Schrijvers DM; Van Spaendonk H; Breynaert A; Hermans N; Van Hoof VO; Takahashi N; Vandenabeele P; Kim SH; De Meyer GRY; Martinet W
Atherosclerosis; 2016 Sep; 252():166-174. PubMed ID: 27425215
[TBL] [Abstract][Full Text] [Related]
52. Macrophage autophagy plays a protective role in advanced atherosclerosis.
Liao X; Sluimer JC; Wang Y; Subramanian M; Brown K; Pattison JS; Robbins J; Martinez J; Tabas I
Cell Metab; 2012 Apr; 15(4):545-53. PubMed ID: 22445600
[TBL] [Abstract][Full Text] [Related]
53. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.
Tao H; Yancey PG; Babaev VR; Blakemore JL; Zhang Y; Ding L; Fazio S; Linton MF
J Lipid Res; 2015 Aug; 56(8):1449-60. PubMed ID: 26059978
[TBL] [Abstract][Full Text] [Related]
54. NOX2 inhibition stabilizes vulnerable plaques by enhancing macrophage efferocytosis via MertK/PI3K/AKT pathway.
Wang Y; Liu XY; Wang Y; Zhao WX; Li FD; Guo PR; Fan Q; Wu XF
Redox Biol; 2023 Aug; 64():102763. PubMed ID: 37354827
[TBL] [Abstract][Full Text] [Related]
55. Limited Macrophage Positional Dynamics in Progressing or Regressing Murine Atherosclerotic Plaques-Brief Report.
Williams JW; Martel C; Potteaux S; Esaulova E; Ingersoll MA; Elvington A; Saunders BT; Huang LH; Habenicht AJ; Zinselmeyer BH; Randolph GJ
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1702-1710. PubMed ID: 29903736
[TBL] [Abstract][Full Text] [Related]
56. Disulfiram Reduces Atherosclerosis and Enhances Efferocytosis, Autophagy, and Atheroprotective Gut Microbiota in Hyperlipidemic Mice.
Traughber CA; Timinski K; Prince A; Bhandari N; Neupane K; Khan MR; Opoku E; Opoku E; Brubaker G; Shin J; Hong J; Kanuri B; Ertugral EG; Nagareddy PR; Kothapalli CR; Cherepanova O; Smith JD; Gulshan K
J Am Heart Assoc; 2024 Apr; 13(8):e033881. PubMed ID: 38563369
[TBL] [Abstract][Full Text] [Related]
57. A nano-bioconjugate modified with anti-SIRPα antibodies and antisense oligonucleotides of mTOR for anti-atherosclerosis therapy.
Liu Y; Huang Q; He M; Chen T; Chu X
Acta Biomater; 2024 Mar; 176():356-366. PubMed ID: 38160854
[TBL] [Abstract][Full Text] [Related]
58. [New insights into the etiopathogenesis of atherosclerosis and atherothrombosis].
Herman AG
Bull Mem Acad R Med Belg; 2006; 161(3-4):213-25; discussion 226-7. PubMed ID: 17172227
[TBL] [Abstract][Full Text] [Related]
59. Design of a Multifunctional Nanozyme for Resolving the Proinflammatory Plaque Microenvironment and Attenuating Atherosclerosis.
He H; Han Q; Wang S; Long M; Zhang M; Li Y; Zhang Y; Gu N
ACS Nano; 2023 Aug; 17(15):14555-14571. PubMed ID: 37350440
[TBL] [Abstract][Full Text] [Related]
60. Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression.
Sharma M; Schlegel MP; Afonso MS; Brown EJ; Rahman K; Weinstock A; Sansbury BE; Corr EM; van Solingen C; Koelwyn GJ; Shanley LC; Beckett L; Peled D; Lafaille JJ; Spite M; Loke P; Fisher EA; Moore KJ
Circ Res; 2020 Jul; 127(3):335-353. PubMed ID: 32336197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
